AU2796799A - Amplification of gene transfer and gene therapy by controlled replication - Google Patents

Amplification of gene transfer and gene therapy by controlled replication

Info

Publication number
AU2796799A
AU2796799A AU27967/99A AU2796799A AU2796799A AU 2796799 A AU2796799 A AU 2796799A AU 27967/99 A AU27967/99 A AU 27967/99A AU 2796799 A AU2796799 A AU 2796799A AU 2796799 A AU2796799 A AU 2796799A
Authority
AU
Australia
Prior art keywords
amplification
gene
controlled replication
gene therapy
gene transfer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU27967/99A
Inventor
David T Curiel
Jesus Gomez-Navarro
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
UAB Research Foundation
Original Assignee
UAB Research Foundation
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by UAB Research Foundation filed Critical UAB Research Foundation
Publication of AU2796799A publication Critical patent/AU2796799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/10011—Adenoviridae
    • C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
    • C12N2710/10341—Use of virus, viral particle or viral elements as a vector
    • C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AU27967/99A 1998-03-03 1999-03-01 Amplification of gene transfer and gene therapy by controlled replication Abandoned AU2796799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7681298P 1998-03-03 1998-03-03
US60076812 1998-03-03
PCT/US1999/004394 WO1999044423A1 (en) 1998-03-03 1999-03-01 Amplification of gene transfer and gene therapy by controlled replication

Publications (1)

Publication Number Publication Date
AU2796799A true AU2796799A (en) 1999-09-20

Family

ID=22134338

Family Applications (1)

Application Number Title Priority Date Filing Date
AU27967/99A Abandoned AU2796799A (en) 1998-03-03 1999-03-01 Amplification of gene transfer and gene therapy by controlled replication

Country Status (2)

Country Link
AU (1) AU2796799A (en)
WO (1) WO1999044423A1 (en)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020006397A1 (en) * 2000-04-28 2002-01-17 Roberts Bruce L. In VIVO loading of MHC
EP1207205A1 (en) * 2000-11-20 2002-05-22 Crucell Holland B.V. Adenoviral replicons
WO2002076468A1 (en) * 2001-03-27 2002-10-03 New York University Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
US7910093B2 (en) 2003-08-19 2011-03-22 New York University Method for detecting cancer cells and monitoring cancer therapy
US7303898B2 (en) 2005-03-29 2007-12-04 New York University Defective sindbis viral vectors
CA2903582C (en) 2013-03-14 2021-06-08 Salk Institute For Biological Studies Oncolytic adenovirus compositions
EP4155411A1 (en) 2016-02-23 2023-03-29 Salk Institute for Biological Studies Exogenous gene expression in therapeutic adenovirus for minimal impact on viral kinetics
JP7054527B2 (en) 2016-02-23 2022-04-14 ソーク インスティテュート フォー バイオロジカル スタディーズ High-throughput assay to measure adenovirus replication kinetics
WO2018111767A1 (en) 2016-12-12 2018-06-21 Salk Institute For Biological Studies Tumor-targeting synthetic adenoviruses and uses thereof

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4214239B2 (en) * 1996-11-19 2009-01-28 ザ ユーナヴァーサティ オブ アラバマ アト バーミングハム リサーチ ファンデーション Bifunctional retrovirus / adenovirus system

Also Published As

Publication number Publication date
WO1999044423A1 (en) 1999-09-10

Similar Documents

Publication Publication Date Title
AU1926001A (en) Novel human protein kinases and protein kinase-like enzymes
AU4787697A (en) Therapeutic gene
HUP0203523A3 (en) The use of bacterial phage associated lysing enzymes for the prophylactic and therapeutic treatment of various illnesses
AU4053699A (en) Novel human genes and gene expression products
AU8242298A (en) Gene transfer method with the use of serum-free medium
AU3737297A (en) Bacteriophage-mediated gene therapy
AU2309700A (en) Oligonucleotide array and methods of use
AU5198398A (en) Mutant human hedgehog gene
AU715620C (en) Therapeutic methods and uses
AU2001245987A1 (en) Compositions and methods for gene therapy
EP0853486A3 (en) Therapeutic applications of animal sera including horse serum in the treatment of aids, cancer, and other viral and bacterial diseases
AU2796799A (en) Amplification of gene transfer and gene therapy by controlled replication
AU2001264769A1 (en) Induction of apoptosis and cell growth inhibition by protein 4.33
AU4961996A (en) Ribozyme-mediated inactivation of leukemia-associated rna
AU1723001A (en) Methods and means for regulation of gene expression
AU5395196A (en) Primers and methods for simultaneous amplification of multip le markers for dna fingerprinting
AU5597500A (en) Streptavidin expressed gene fusions and methods of use thereof
AU2001251138A1 (en) Compositions and methods for tissue specific gene regulation therapy
AU2001234544A1 (en) Novel human protein kinases and protein kinase-like enzymes
AU6254799A (en) Anti-ige gene therapy
AU3518695A (en) Gene therapy for transplantation and inflammatory or thrmbotic conditions
AU2001269077A1 (en) Methods and means for regulation of gene expression
AU6263999A (en) Human genes and gene expression products
AU2001292310A1 (en) Method of regulating the activity of expression product of gene transferred intoliving body
AU1040700A (en) The genetic determination of genes and its use for the prophylaxis and therapy of diseases

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase